Recently filed court documents show the makers of Tylenol planned to enlist the White House and lawmakers to block the Food and Drug Administration from imposing tough new safety restrictions on acetaminophen, the iconic painkiller’s chief ingredient. An executive with McNeil Consumer Healthcare – which counts Tylenol as its flagship product – told the board…

To continue reading, please login or subscribe. Now 249,304 readers! Our subscriptions start at $2/month:

Login Subscribe